Bandhita Wanikorn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bandhita Wanikorn has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Narongsuk Munkong
Department of Pathology, School of Medicine, University of Phayao, Phayao, Thailand
2 shared publications - Surasawadee Somnuk
Department of Sports Science, Faculty of Sports and Health Science, Kasetsart University, Kamphaeng Saen Campus, Nakhon Pathom 73140, Thailand
2 shared publications - Surat Komindr
Division of Nutrition and Biochemical Medicine, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
2 shared publications - Wason Parklak
School of Health Sciences Research, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
2 shared publications - Hataichanok Chuljerm
School of Health Sciences Research, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - Kanokwan Kulprachakarn
School of Health Sciences Research, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication
Latest Publications
- Open Access
Impact of Mango Puree Supplementation on Inflammatory, Muscle Damage, and Selected T-Cell Biomarkers in Elite Beach Volleyball Players During Regular Training
Background/Objectives: Mango is a tropical fruit rich in polyphenols and carotenoids that may support recovery-related physiological responses during athletic training. This study examined the effects of mango puree supplementation on inflammatory biomarkers, muscle damage, and selected T-cell subsets in Thai men’s national beach volleyball players during regular training. Methods: Fifteen male athletes completed a pilot randomized, single-blind, crossover trial. Participants consumed the mango puree or placebo (600 g/day) for 4 weeks, separated by a 2-week washout period. Blood samples and physiological measurements were collected at baseline and at the end of each intervention period. Outcomes were analyzed using linear mixed-effects models. Results: Mango puree supplementation was associated with lower concentrations of C-reactive protein (mean difference: −1.6 mg/L; 95% CI: −2.1 to −1.1; p < 0.001), interleukin-6 (−0.7 pg/mL; 95% CI: −1.2 to −0.3; p = 0.003), and creatine kinase (−290.1 U/L; 95% CI: −356.1 to −224.1; p < 0.001) compared with the placebo. The percentage of CD4+ T cells (9.82 percentage points; 95% CI: 5.0 to 14.6; p < 0.001) and the CD4/CD8 ratio (0.37; 95% CI: 0.11 to 0.63; p = 0.007) were higher during mango puree supplementation, while CD8+ T-cell percentage did not differ between conditions. No significant treatment effects were observed for body composition parameters or blood pressure (all p > 0.05). Total energy intake remained unchanged across intervention periods (p > 0.05). Conclusions: Mango puree supplementation during regular training was associated with lower inflammatory and muscle damage biomarkers and alterations in selected T-cell subsets compared with the placebo.
Open AccessImpact of Mango Puree Supplementation on Inflammatory, Muscle Damage, and Selected T-Cell Biomarkers in Elite Beach Volleyball Players During Regular Training
Background/Objectives: Mango is a tropical fruit rich in polyphenols and carotenoids that may support recovery-related physiological responses during athletic training. This study examined the effects of mango puree supplementation on inflammatory biomarkers, muscle damage, and selected T-cell subsets in Thai men’s national beach volleyball players during regular training. Methods: Fifteen male athletes completed a pilot randomized, single-blind, crossover trial. Participants consumed the mango puree or placebo (600 g/day) for 4 weeks, separated by a 2-week washout period. Blood samples and physiological measurements were collected at baseline and at the end of each intervention period. Outcomes were analyzed using linear mixed-effects models. Results: Mango puree supplementation was associated with lower concentrations of C-reactive protein (mean difference: −1.6 mg/L; 95% CI: −2.1 to −1.1; p < 0.001), interleukin-6 (−0.7 pg/mL; 95% CI: −1.2 to −0.3; p = 0.003), and creatine kinase (−290.1 U/L; 95% CI: −356.1 to −224.1; p < 0.001) compared with the placebo. The percentage of CD4+ T cells (9.82 percentage points; 95% CI: 5.0 to 14.6; p < 0.001) and the CD4/CD8 ratio (0.37; 95% CI: 0.11 to 0.63; p = 0.007) were higher during mango puree supplementation, while CD8+ T-cell percentage did not differ between conditions. No significant treatment effects were observed for body composition parameters or blood pressure (all p > 0.05). Total energy intake remained unchanged across intervention periods (p > 0.05). Conclusions: Mango puree supplementation during regular training was associated with lower inflammatory and muscle damage biomarkers and alterations in selected T-cell subsets compared with the placebo.
- Open Access
Nutraceutical Properties of Thai Mulberry (Morus alba L.) and Their Effects on Metabolic and Cardiovascular Risk Factors in Individuals with Obesity: A Randomized, Single-Blind Crossover Trial
Background/Objectives: Mulberries exhibit antioxidant properties that may attenuate metabolic abnormalities. Kamphaeng Saen mulberry (KPS-MB-42-1) contains anthocyanins, polyphenols, and nutrients, but few studies have explored its benefits for human health. This study investigated the effects of a concentrated mulberry drink (CMD) from the KPS-MB-42-1 cultivar on metabolic and cardiovascular risk factors in obese individuals. Methods: A single-blind, randomized crossover clinical pilot trial was performed on individuals with obesity. Participants consumed 100 g of CMD daily, alternating with placebo for 6 weeks. Body composition, blood pressure, and blood samples were assessed at baseline and post-intervention. Results: This study was completed with 12 participants (7 men, 5 women, aged 30–55 years, BMI 32.1 ± 5.98 kg/m2) consuming CMD with 1041.90 mg total phenolic compounds and 35.34 mg total anthocyanins. No significant changes in body composition were observed. CMD consumption significantly reduced systolic and diastolic blood pressure, and mean arterial pressure, compared to baseline and placebo periods (p < 0.05). While total cholesterol, LDL-C, and HDL-C remained unchanged, triglycerides were significantly lower during CMD consumption compared to placebo periods (p < 0.05). Fasting plasma glucose (FPG) levels were stable during CMD consumption but increased significantly with the placebo period (p < 0.05). C-reactive protein levels were also significantly lower during CMD consumption compared to placebo periods (p < 0.05). No changes in blood coagulation indicators (prothrombin time, activated partial thromboplastin time, and the international normalized ratio) were found. Conclusions: CMD improved metabolic markers, particularly regarding its antihypertensive effects. These findings highlight CMD’s potential as a health drink for managing metabolic syndrome and preventing chronic diseases.
Open AccessNutraceutical Properties of Thai Mulberry (Morus alba L.) and Their Effects on Metabolic and Cardiovascular Risk Factors in Individuals with Obesity: A Randomized, Single-Blind Crossover Trial
Background/Objectives: Mulberries exhibit antioxidant properties that may attenuate metabolic abnormalities. Kamphaeng Saen mulberry (KPS-MB-42-1) contains anthocyanins, polyphenols, and nutrients, but few studies have explored its benefits for human health. This study investigated the effects of a concentrated mulberry drink (CMD) from the KPS-MB-42-1 cultivar on metabolic and cardiovascular risk factors in obese individuals. Methods: A single-blind, randomized crossover clinical pilot trial was performed on individuals with obesity. Participants consumed 100 g of CMD daily, alternating with placebo for 6 weeks. Body composition, blood pressure, and blood samples were assessed at baseline and post-intervention. Results: This study was completed with 12 participants (7 men, 5 women, aged 30–55 years, BMI 32.1 ± 5.98 kg/m2) consuming CMD with 1041.90 mg total phenolic compounds and 35.34 mg total anthocyanins. No significant changes in body composition were observed. CMD consumption significantly reduced systolic and diastolic blood pressure, and mean arterial pressure, compared to baseline and placebo periods (p < 0.05). While total cholesterol, LDL-C, and HDL-C remained unchanged, triglycerides were significantly lower during CMD consumption compared to placebo periods (p < 0.05). Fasting plasma glucose (FPG) levels were stable during CMD consumption but increased significantly with the placebo period (p < 0.05). C-reactive protein levels were also significantly lower during CMD consumption compared to placebo periods (p < 0.05). No changes in blood coagulation indicators (prothrombin time, activated partial thromboplastin time, and the international normalized ratio) were found. Conclusions: CMD improved metabolic markers, particularly regarding its antihypertensive effects. These findings highlight CMD’s potential as a health drink for managing metabolic syndrome and preventing chronic diseases.